Skip to content

Avanos Medical AVNS Income Tax Reconciliation Change In Enacted Tax Rate

Income Tax Reconciliation Change In Enacted Tax Rate at other companies

Avanos Medical logo
Avanos MedicalAVNS
$0
Schneider National logo
Schneider NationalSNDR
-$175K
KEE
Keel Infrastructure Corp. Common StockKEEL
-$507K-475%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
-$29.75K-106%
eXp World Holdings, Inc. Common Stock logo
eXp World Holdings, Inc. Common StockAGNT
$0
Zymeworks logo
ZymeworksZYME
$0

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's income tax reconciliation change in enacted tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's income tax reconciliation change in enacted tax rate?
Avanos Medical (AVNS) reported income tax reconciliation change in enacted tax rate of $0 in Q4 2025.
What does income tax reconciliation change in enacted tax rate mean?
Reflects adjustments to income tax expense resulting from changes in enacted tax laws or rates during the reporting period. It helps investors isolate the impact of legislative tax changes on the company's financial performance.